Monday, December 11, 2006 7:00:00 AM PDT | VentureDeal Staff
MA -- Therion Biologics has shut its operations
and filed for bankruptcy under Chapter 7, which protects the company while it
proceeds to an orderly and complete liquidation of its assets.
The company had failed in its clinical trials of its prostate cancer and
pancreatic cancer drug candidates. After it announced the failed results
in June, the company's main creditor, Hans-Werner Hector, cut off a $50 million
line of credit he had extended the company, which the company had apparently
drawn down by $20 million.
Jeoffrey L. Burtch, of Cooch & Taylor in Wilmington, Delaware
has been appointed trustee for the liquidation.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
© VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.